Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-12-01T03:55:16.620Z Has data issue: false hasContentIssue false

Pharmacokinetics of Antimicrobial Agents

Published online by Cambridge University Press:  02 January 2015

Sandra M. Norris
Affiliation:
School of Medicine, University of Virginia, Charlottesville, Virginia
Daniel A. Spyker
Affiliation:
School of Medicine, University of Virginia, Charlottesville, Virginia

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1984

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Greenblatt, DJ, Koch-Weser, J, Clinical pharmacokinetics (first of two parts). N Engl J Med 1975;293:702705.CrossRefGoogle ScholarPubMed
2.Gibaldi, M, Boyes, RN, Feldman, S, Influence of first-pass effect on availability of drugs on oral administration, J Pharm Sci 1971;60:13381340.CrossRefGoogle ScholarPubMed
3.Finn, AL, Taylor, WJ, Kane, WJ, General principles. Practical applications of serum concentration monitoring, in Individualizing Drug Therapy: Practical Application of Drug Monitoring. New York, Gross Townsend Frank Inc, 1981, pp 230.Google Scholar
4.Hurwitz, A, Antacid therapy and drug kinetics. Clin Pharmacokinet 1977;2:269280.CrossRefGoogle ScholarPubMed
5.Thompson, MIB, Russo, ME, Saxon, BJ, et al: Gentamicin inactivation by piperacillin or carbenicillin in patients with end-stage renal disease. Antimicrob Agents Chemother 1982;21:268273.CrossRefGoogle ScholarPubMed
6.Ervin, FR, Bullock, WE, Nuttall, CE, Inactivation of gentamicin by penicillins in patients with renal failure. Antimicrob Agents Chemother 1976;9:10041011.CrossRefGoogle ScholarPubMed
7.Blair, DC, Duggan, DO, Schroeder, ET, Inactivation of amikacin and gentamicin by carbenicillin in patients with end-stage renal failure. Antimicrob Agents Chemother 1982;22:376379.CrossRefGoogle ScholarPubMed
8.Glazko, AJ, Dill, WA, Kinkel, AW, et al: Absorption and excretion of parenteral doses of chloramphenicol sodium succinate in comparison with peroral doses of chloramphenicol. Clin Pharmacol Ther 1977;21:104.Google Scholar
9.Brogden, RN, Heel, RC, Speight, TM, et al: Metronidazole in anaerobic infections: A review of its activity, pharmacokinetics and therapeutic use. Drugs 1978;16:387417.CrossRefGoogle ScholarPubMed
10.Greenblatt, DJ, Koch-Weser, J, Intramuscular injection of drugs. N Engl J Med 1976;295:542546.Google ScholarPubMed
11.Wise, R, Protein binding of B-lactams: The ef fects on activity and pharmacology particularly tissue penetration. Antimicrob Agents Chemother 1983;12:105118.CrossRefGoogle Scholar
12.Eliopoulis, GM, Moellering, RC, Azlocillin, mezlocillin and piperacillin: New broad-spectrum penicillins. Ann Intern Med 1982;97:755760.CrossRefGoogle Scholar
13.Greenblatt, DJ, Koch-Weser, J, Clinical pharmacokinetics (second of two parts). NEngl J Med 1975;293:964970.CrossRefGoogle ScholarPubMed
14.Lesar, TS, Rotschafer, JC, Strand, LM, et al: Gentamicin dosing errors with four commonly used nomograms. JAMA 1982;248:11901193.CrossRefGoogle ScholarPubMed
15.Cockcroft, DW, Gault, MH, Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31.CrossRefGoogle ScholarPubMed
16.Spyker, DA, Guerrant, RL, Dosage nomograms for aminoglycoside antibiotics. Hospital Formulary 1981;16:132139.Google Scholar
17.Siersbaek-Nielson, K, Molholm-Hansen, J, Kampmann, J, Rapid evaluation of creatinine clearance. Lancet 1971;1:1133.CrossRefGoogle Scholar